Source comparison
PT-141 Cycle Length: Dosing Protocol Comparison
The table below compares common PT-141 dosing protocols based on administration frequency, total cycle duration, and washout requirements. Each approach produces different receptor exposure profiles and sustainability outcomes. Daily Dosing 1.5–2.0mg every 24
This comparison does not assign a generated winner or score.
- The table below compares common PT-141 dosing protocols based on administration frequency, total cycle duration, and washout requirements. Each approach produces different receptor exposure profiles and sustainability outcomes.
- Daily Dosing
- 1.5–2.0mg every 24 hours
- 4–6 weeks maximum
- 6–8 weeks required
- Severe downregulation by week 3–4; MC4R density reduced 40–60%
- Poor. Efficacy loss within 4 weeks; subsequent cycles show minimal response
- Not recommended. Rapid desensitization outweighs any convenience benefit. Receptor recovery requires washout periods longer than the cycle itself.
- Every-Other-Day
- 1.5–2.0mg every 48 hours
- 6–8 weeks
- 4 weeks minimum
- Moderate downregulation; partial receptor recovery between doses
- Moderate. Efficacy maintained through week 6, declines thereafter
- Acceptable for short research windows but suboptimal for multi-cycle studies. 48-hour intervals insufficient for full homologous desensitization reversal.
- 2–3 Times Weekly
- 1.5–2.0mg Mon/Thu or Mon/Wed/Fri
- 8–12 weeks
- 4 weeks standard
- Minimal downregulation; 60–72 hour intervals allow receptor recovery
- Excellent. Sustained efficacy through 12 weeks; receptor sensitivity maintained across multiple cycles with proper washout
- Recommended standard. Balances adequate exposure frequency with receptor preservation. Supported by clinical trial data and receptor biology literature.
- Pulse Protocol
- 2.0–2.5mg once weekly
- 12–16 weeks
- 2–3 weeks
- Negligible downregulation; extended recovery between exposures
- Variable. Effective for applications tolerating infrequent dosing; may not maintain steady-state effects
- Appropriate for specific research designs requiring intermittent exposure. Not suitable for applications needing consistent weekly effects.